Physician profile
Daniel J Martin
NPI 1265505622
$38,034.91
in general payments reported to CMS, 2019-2025
32 companies · $8,757 in 2025
The $8,757 reported for 2025 was more than what 89% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,613 · 2020: $1,575 · 2021: $3,966 · 2022: $1,729 · 2023: $6,418 · 2024: $7,978 · 2025: $8,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23K · Travel and Lodging: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22,849.37 |
| Travel and Lodging | $302.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $29,365.53 | 2019-2025 | Afx2 Bifurcated Endograft System, Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $3,567.76 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $1,546.39 | 2019-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Stryker Corporation | $479.10 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Janssen Pharmaceuticals, INC | $393.12 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $350.62 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $303.08 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $299.62 | 2019-2024 | Artegraft Vascular Graft |
| Philips North America LLC | $218.25 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $209.36 | 2019-2024 | Eliquis |
| Bard Peripheral Vascular, INC. | $176.43 | 2019-2024 | Venovo, Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $158.82 | 2019 | |
| Atricure, INC. | $137.30 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Abbott Laboratories | $112.78 | 2019-2024 | Jeti, Diamondback Peripheral, Jeti All In One Non-Sterile Kit |
| Penumbra, INC. | $93.38 | 2019-2025 | Indigo System, Penumbra System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $88.69 | 2019-2023 | Zilver Ptx |
| Medtronic, INC. | $78.71 | 2023-2025 | In.Pact Admiral, Abre |
| Silk Road Medical, INC. | $67.15 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Neuros Medical, INC. | $62.65 | 2025 | Altius |
| Smith+Nephew, INC. | $51.80 | 2023-2025 | Collagenase Santyl, Regranex |
| Angiodynamics, INC. | $45.55 | 2025 | Alphavac |
| Lilly USA, LLC | $43.85 | 2021 | |
| Ethicon US, LLC | $26.24 | 2024 | Ethicon, Prolene, Surgicel Nu-Knit |
| Biom'Up Sa | $25.31 | 2019 | |
| Ekos Corporation | $24.03 | 2019 | |
| Sanara Medtech INC. | $20.44 | 2025 | Celleraterx |
| Reflow Medical INC | $17.72 | 2025 | |
| Elutia, INC. | $16.00 | 2020 | |
| Bioventus LLC | $14.97 | 2022 | |
| Boston Scientific Corporation | $14.81 | 2025 | Enroute Transcarotid Neuroprotection System |
| Paratek Pharmaceuticals, INC. | $13.70 | 2023 | Nuzyra |
| Medline Industries LP | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.